Arca
Skip to content

Human papilloma virus (hpv)

Drug research and approvals for human papilloma virus (hpv): what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 16, 2026, 143 studies of human papilloma virus (hpv) are recruiting on ClinicalTrials.gov, Health Canada has authorized 7 drug trials for it since 2013, FDA has 0 approved and 6 open orphan designations naming it, and the EU has 1 authorised medicine for it.

  • Recruiting worldwide: 143
  • Trials authorized in Canada: 7
  • FDA orphan approvals: 0
  • EU medicines: 1

Recruiting Now

Newest start dates first, of 143 recruiting on ClinicalTrials.gov ↗

Trials Authorized in Canada

Newest first; search them all in Canada trials
May 23, 2023Phase 2a multicenter, randomized, double-blinded, placebo-controlled clinical trial to evaluate the safety and efficacy of topical nitric oxide releasing…NITRIC OXIDESANOTIZE RESEARCH & DEVELOPMENT CORPClosed
Feb 25, 2022Molecular residual disease interception in locoregionally-advanced high risk hpv+ and hpv- hnscc (meridian)AZD2936PRINCESS MARGARET CANCER CENTREOngoing
Jan 17, 2018A phase 1/1b, multicenter, open-label trial of oncolytic mg1 expressing mutant human papilloma virus (hpv) e6 and e7 (mg1-e6e7), with adenovirus vaccine…AD-E6E7 / MG1-E6E7/ KEYTRUDATURNSTONE BIOLOGICSClosed
Jun 10, 2016Long term immune memory responses to human papillomavirus (hpv) vaccination following 2 versus 3 doses of quadrivalent hpv vaccineGARDASILVACCINE EVALUATION CENTER, UNIVERSITY OF BRITISH COLOMBIAPending
Apr 16, 2015"essai clinique visant a documenter l'immunogenicite et l'innocuite des vaccins gardasil 9 et cervarix administres de facon interchangeable aux jeunes de 9-10…GARDASIL 9/CERVARIXCENTRE HOSPITALIER UNIVERSITAIRE DE QUEBECPending
Apr 24, 2014A phase III randomized, international, placebo-controlled, double-blind clinical trial to study the tolerability and immunogenicity of v503, a multivalent…V503 (NONVALENT HPV L1 VLP VACCINE)Merck & Co. (MSD)Ongoing
Oct 17, 2013A phase III clinical trial to study the tolerability and immunogenicity of a 2-dose regimen of v503, a multivalent human papillomavirus (hpv) l1 virus-like…V503 (NONAVALENT HPV L1 VLP VACCINE)Merck & Co. (MSD)Ongoing

FDA Orphan Designations

Approved first, then open designations, newest first
Dec 1, 2020Human autologous CD4+ and CD8+ T cells engineered ex vivo…Treatment of patients with human papillomavirus (HPV)+ cervical cancer who are human leukocyte antigen (HLA)-A*02+Kite Pharma, Inc.Designated
Sep 4, 2014Adenovirus serotype-5 (Ad5) vector that contains a modified…Treatment of human papillomavirus (HPV)-associated head and neck squamous cell carcinoma (HNSCC)Etubics CorporationDesignated
Nov 4, 2013live attenuated bioengineered Listeria monocytogenes…Treatment of human papilloma virus-associated head and neck cancerAyala Pharmaceuticals, Inc.Designated
Aug 12, 2013ADXS11-001Treatment of HPV-positive associated anal cancerAdvaxis, Inc.Designated
Sep 1, 2011HPV16 E6/E7 synthetic long peptides vaccineTreatment of epithelial neoplasias of the vulva positive for human papilloma virus type 16.ISA Therapeutics BVDesignated
Jan 12, 2009HPV-16 cancer therapeutic trojan peptide vaccineTreatment of HPV-16 expressing head and neck squamous cell carcinoma.Gliknik, Inc.Designated

Medicines Authorised in the EU

Newest first
AuthorisedMedicineHolderEPAR
Jun 10, 2015Gardasil 9human papillomavirus 9-valent vaccine (recombinant, adsorbed)Merck Sharp & Dohme B.V.EMA ↗

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.